Grail, INC. (GRAL) — SEC Filings

Q: What are the key financial highlights for Grail, INC.?

Key financial highlights for Grail, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Grail, INC.?

Key executives at Grail, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Grail, INC. stock?

Risk factors for Grail, INC. (GRAL) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Grail, INC.?

Forward-looking statements and predictions from Grail, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Grail, INC.. Recent 4 filing on Apr 9, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Grail, INC. on SEC EDGAR

Overview

Grail, INC. (GRAL) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 144 filed on Apr 6, 2026: On April 6, 2026, GRAIL, Inc. filed a Form 144, indicating a proposed sale of securities. The filing was made by Robert P. Ragusa, associated with the company, from the mailing address 1525 O'Brien Drive, Menlo Park, CA 94025.

Sentiment Summary

Across 34 filings, the sentiment breakdown is: 1 bearish, 31 neutral, 2 mixed. The dominant filing sentiment for Grail, INC. is neutral.

Filing Type Overview

Grail, INC. (GRAL) has filed 1 4, 1 144, 18 8-K, 5 10-Q, 1 DEF 14A, 1 10-K, 4 SC 13G, 1 SC 13G/A, 2 8-K/A with the SEC between Jun 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (34)

4 Filing — 4 · Apr 9, 2026
GRAIL, Inc. Files Form 144 for Proposed Securities Sale — 144 · Apr 6, 2026 Risk: medium
On April 6, 2026, GRAIL, Inc. filed a Form 144, indicating a proposed sale of securities. The filing was made by Robert P. Ragusa, associated with the company,
GRAIL, Inc. Files 8-K: Other Events & Exhibits — 8-K · Nov 14, 2025 Risk: low
GRAIL, Inc. filed an 8-K on November 14, 2025, reporting on events that occurred on November 13, 2025. The filing primarily concerns "Other Events" and "Financi
GRAIL Narrows Losses, Boosts Revenue Post-Illumina Spin-Off — 10-Q · Nov 13, 2025 Risk: medium
GRAIL, Inc. (GRAL) reported a net loss of $88.977 million for the three months ended September 30, 2025, a significant improvement from the $125.688 million net
GRAIL, Inc. Files 8-K on Financials — 8-K · Nov 12, 2025 Risk: low
GRAIL, Inc. filed an 8-K on November 12, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
GRAIL, Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Oct 20, 2025 Risk: medium
GRAIL, Inc. filed an 8-K on October 20, 2025, reporting on events that occurred on October 18, 2025. The filing indicates an entry into a material definitive ag
GRAIL, Inc. Files 8-K with Material Agreements & Financials — 8-K · Oct 16, 2025 Risk: medium
GRAIL, Inc. filed an 8-K on October 16, 2025, reporting on a material definitive agreement, results of operations, unregistered sales of equity securities, and
GRAIL, Inc. Enters Material Definitive Agreement — 8-K · Sep 18, 2025 Risk: medium
On September 11, 2025, GRAIL, Inc. entered into a material definitive agreement, likely related to its financial obligations. The company, previously known as G
GRAIL Narrows Losses Significantly, Revenue Up Amid Cost Cuts — 10-Q · Aug 13, 2025 Risk: high
GRAIL, Inc. reported a net loss of $113.985 million for the three months ended June 30, 2025, a significant improvement from the $1.585 billion net loss in the
GRAIL, Inc. Files 8-K on Financials — 8-K · Aug 12, 2025 Risk: low
GRAIL, Inc. filed an 8-K on August 12, 2025, reporting on its results of operations and financial condition, and filing financial statements and exhibits. The f
GRAIL, Inc. Files 8-K on Shareholder Vote Matters — 8-K · May 30, 2025 Risk: low
GRAIL, Inc. filed an 8-K on May 30, 2025, reporting on matters submitted to a vote of security holders as of May 29, 2025. The filing details the company's prin
GRAIL, Inc. Files 8-K: Board and Officer Changes — 8-K · May 16, 2025 Risk: low
GRAIL, Inc. filed an 8-K on May 16, 2025, reporting changes in its board of directors and certain officers. The filing also includes information on compensatory
GRAIL, Inc. Files Q1 2025 10-Q — 10-Q · May 14, 2025 Risk: medium
GRAIL, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025.
GRAIL, Inc. Files 8-K on Financials — 8-K · May 13, 2025 Risk: low
On May 13, 2025, GRAIL, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhib
GRAIL, Inc. Files 2025 Proxy Statement — DEF 14A · Apr 15, 2025 Risk: low
GRAIL, Inc. filed its definitive proxy statement on April 15, 2025, for its annual meeting of stockholders on May 29, 2025. The filing covers the fiscal year en
GRAIL, Inc. Files 2024 10-K — 10-K · Mar 5, 2025 Risk: medium
GRAIL, Inc. filed its 2024 10-K on March 5, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as GRAIL, LLC, is focused o
GRAIL, Inc. Files 8-K on Financials — 8-K · Feb 20, 2025 Risk: low
GRAIL, Inc. filed an 8-K on February 20, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits.
GRAIL, Inc. Files 8-K on Financials — 8-K · Jan 15, 2025 Risk: low
GRAIL, Inc. filed an 8-K on January 15, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. T
SC 13G Filing — SC 13G · Nov 14, 2024
GRAIL, Inc. Files Q3 2024 10-Q — 10-Q · Nov 13, 2024 Risk: medium
GRAIL, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported revenue from its screening services. Specific financial figures and op
SC 13G Filing — SC 13G · Nov 12, 2024
GRAIL, Inc. Files 8-K on Financials — 8-K · Nov 12, 2024 Risk: low
GRAIL, Inc. filed an 8-K on November 12, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
GRAIL, Inc. Appoints New CMO, Director — 8-K · Oct 22, 2024 Risk: low
GRAIL, Inc. announced on October 21, 2024, the appointment of Dr. Tracey Gronemus as Chief Medical Officer and the election of Ms. Jennifer D. Johnson to its Bo
SC 13G/A Filing — SC 13G/A · Sep 30, 2024
SC 13G Filing — SC 13G · Aug 30, 2024
SC 13G Filing — SC 13G · Aug 14, 2024
GRAIL, Inc. Files 10-Q for Q2 2024 — 10-Q · Aug 13, 2024 Risk: medium
GRAIL, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and operational updates. Specific financial figures a
GRAIL, Inc. Files 8-K for Regulation FD Disclosure — 8-K · Aug 6, 2024 Risk: low
GRAIL, Inc. filed an 8-K on August 6, 2024, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyo
GRAIL, Inc. Amends Officer and Director Filings — 8-K/A · Jul 2, 2024 Risk: low
GRAIL, Inc. filed an 8-K/A on July 2, 2024, to amend its previous filing regarding the departure of certain officers and the election of directors. Specifically
GRAIL Takes $1.1B Impairment Charge on Galleri Test — 8-K · Jun 27, 2024 Risk: medium
GRAIL, Inc. reported a material impairment charge of approximately $1.1 billion on June 24, 2024. This charge is primarily related to the company's decision to
GRAIL, Inc. Files 8-K: Material Agreements & Corporate Changes — 8-K · Jun 24, 2024 Risk: medium
GRAIL, Inc. announced on June 21, 2024, a material definitive agreement and changes related to its security holders' rights. The filing also details changes in
GRAIL, LLC Converts to GRAIL, Inc. — 8-K · Jun 12, 2024 Risk: medium
GRAIL, LLC announced on June 11, 2024, that it is converting from a limited liability company to a corporation named GRAIL, Inc. This corporate restructuring is
GRAIL, LLC Converts to GRAIL, Inc. — 8-K/A · Jun 6, 2024 Risk: low
GRAIL, LLC filed an 8-K/A on June 6, 2024, to report a corporate conversion. Effective June 3, 2024, GRAIL, LLC converted into a Delaware corporation named GRAI
GRAIL, LLC Converts to GRAIL, Inc. — 8-K · Jun 3, 2024 Risk: low
GRAIL, LLC announced on June 3, 2024, its conversion into a corporation named GRAIL, Inc., incorporated in Delaware. This change is effective as of the filing d

Risk Profile

Risk Assessment: Of GRAL's 28 recent filings, 1 were flagged as high-risk, 12 as medium-risk, and 15 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Grail, INC.'s most recent 10-Q filing (Nov 13, 2025):

Revenue: $36.194M
Net Income: -$88.977M
EPS: -$2.46
Debt-to-Equity: 0.16
Cash Position: $126.892M
Operating Margin: -200.9%
Total Assets: $2.601B
Total Debt: $361.068M

Key Executives

Robert P. Ragusa
Dr. Tracey Gronemus
Ms. Jennifer D. Johnson

Industry Context

GRAIL operates in the rapidly evolving field of multi-cancer early detection (MCED) diagnostics. The industry is characterized by significant scientific innovation, high R&D investment, and intense competition from both established players and startups. Regulatory hurdles and the need for robust clinical validation and payer reimbursement are critical factors for success.

Top Tags

8-k (6) · financial-reporting (6) · financials (5) · filing (3) · material-agreement (3) · corporate-governance (3) · 10-Q (3) · healthcare (3) · Biotechnology (2) · Cancer Diagnostics (2)

Key Numbers

Total Revenue (Q3 2025): $36.194M — Increased from $28.652M in Q3 2024, showing 26.3% growth.
Screening Revenue (Q3 2025): $32.807M — Up from $25.374M in Q3 2024, indicating strong product adoption.
Net Loss (Q3 2025): $88.977M — Reduced from $125.688M in Q3 2024, a 29.2% improvement.
Net Loss (YTD Q3 2025): $309.175M — Significantly lower than $1.929B in YTD Q3 2024, primarily due to a large 2024 impairment.
Research and Development (Q3 2025): $48.647M — Decreased from $78.231M in Q3 2024, reflecting cost optimization.
Sales and Marketing (Q3 2025): $25.503M — Reduced from $35.625M in Q3 2024, indicating efficiency efforts.
Cash and Cash Equivalents (Sep 30, 2025): $126.892M — Down from $214.234M at Dec 31, 2024, highlighting cash burn.
Short-term Marketable Securities (Sep 30, 2025): $413.238M — Provides additional liquidity alongside cash.
Net Cash Used in Operating Activities (YTD Q3 2025): $235.222M — Indicates ongoing cash consumption from operations.
Common Shares Outstanding (Sep 30, 2025): 36,160,998 — Increased from 33,893,409 at Dec 31, 2024, due to stock-based compensation and RSU releases.
SEC File Number: 001-42045 — Identifies GRAIL, Inc.'s filing with the SEC.
IRS Employer Identification No.: 86-3673636 — Tax identification number for GRAIL, Inc.
Filing Date: 10/16/2025 — Date of the 8-K filing
Net Loss (Q2 2025): $113.985M — Significantly reduced from $1.585B in Q2 2024, indicating improved financial performance.
Total Revenue (Q2 2025): $35.544M — Increased from $31.970M in Q2 2024, primarily driven by screening revenue growth.

Related Companies

ILMN

Frequently Asked Questions

What are the latest SEC filings for Grail, INC. (GRAL)?

Grail, INC. has 34 recent SEC filings from Jun 2024 to Apr 2026, including 18 8-K, 5 10-Q, 4 SC 13G. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of GRAL filings?

Across 34 filings, the sentiment breakdown is: 1 bearish, 31 neutral, 2 mixed. The dominant sentiment is neutral.

Where can I find Grail, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Grail, INC. (GRAL) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Grail, INC.?

Key financial highlights from Grail, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for GRAL?

The investment thesis for GRAL includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Grail, INC.?

Key executives identified across Grail, INC.'s filings include Robert P. Ragusa, Dr. Tracey Gronemus, Ms. Jennifer D. Johnson.

What are the main risk factors for Grail, INC. stock?

Of GRAL's 28 assessed filings, 1 were flagged high-risk, 12 medium-risk, and 15 low-risk.

What are recent predictions and forward guidance from Grail, INC.?

Forward guidance and predictions for Grail, INC. are extracted from SEC filings as they are enriched.